Effect of Guaifenesin on Cough Reflex Sensitivity

Research output: Contribution to journalArticle

69 Citations (Scopus)

Abstract

Background: Guaifenesin, a commonly used agent for the treatment of cough, is termed an expectorant since it is believed to alleviate cough discomfort by increasing sputum volume and decreasing its viscosity, thereby promoting effective cough. Despite its common usage, relatively few studies, yielding contrasting results, have been performed to investigate the action and efficacy of guaifenesin. Study objectives: To evaluate the effect of guaifenesin on cough reflex sensitivity. Design: Randomized, double-blind, placebo-controlled trial. Setting: Academic medical center. Participants: Fourteen subjects with acute viral upper respiratory tract infection (URI) and 14 healthy volunteers. Interventions: On 2 separate days, subjects underwent capsaicin cough challenge 1 to 2 h after receiving a single, 400-mg dose (capsules) of guaifenesin or matched placebo. Measurements and results: The concentration of capsaicin inducing five or more coughs (C5) was determined. Among subjects with URI, mean (± SEM) log C5 after guaifenesin and placebo were 0.92 ± 0.17 and 0.66 ± 0.14, respectively (p = 0.028). No effect on cough sensitivity was observed in healthy volunteers. Conclusions: Our results demonstrate that guaifenesin inhibits cough reflex sensitivity in subjects with URI, whose cough receptors are transiently hypersensitive, but not in healthy volunteers. Possible mechanisms include a central antitussive effect, or a peripheral effect by increased sputum volume serving as a barrier shielding cough receptors within the respiratory epithelium from the tussive stimulus.

Original languageEnglish (US)
Pages (from-to)2178-2181
Number of pages4
JournalChest
Volume124
Issue number6
DOIs
StatePublished - Dec 2003

Fingerprint

Guaifenesin
Cough
Reflex
Respiratory Tract Infections
Healthy Volunteers
Capsaicin
Placebos
Sputum
Antitussive Agents
Expectorants
Respiratory Mucosa
Viscosity
Capsules

Keywords

  • Capsaicin
  • Common cold
  • Cough
  • Cough reflex
  • Expectorant
  • Guaifenesin
  • Respiratory tract infection

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Effect of Guaifenesin on Cough Reflex Sensitivity. / Dicpinigaitis, Peter Vytautas; Gayle, Yvonne E.

In: Chest, Vol. 124, No. 6, 12.2003, p. 2178-2181.

Research output: Contribution to journalArticle

Dicpinigaitis, Peter Vytautas ; Gayle, Yvonne E. / Effect of Guaifenesin on Cough Reflex Sensitivity. In: Chest. 2003 ; Vol. 124, No. 6. pp. 2178-2181.
@article{ab729eef7e964b0e8bc331d9ba8ee724,
title = "Effect of Guaifenesin on Cough Reflex Sensitivity",
abstract = "Background: Guaifenesin, a commonly used agent for the treatment of cough, is termed an expectorant since it is believed to alleviate cough discomfort by increasing sputum volume and decreasing its viscosity, thereby promoting effective cough. Despite its common usage, relatively few studies, yielding contrasting results, have been performed to investigate the action and efficacy of guaifenesin. Study objectives: To evaluate the effect of guaifenesin on cough reflex sensitivity. Design: Randomized, double-blind, placebo-controlled trial. Setting: Academic medical center. Participants: Fourteen subjects with acute viral upper respiratory tract infection (URI) and 14 healthy volunteers. Interventions: On 2 separate days, subjects underwent capsaicin cough challenge 1 to 2 h after receiving a single, 400-mg dose (capsules) of guaifenesin or matched placebo. Measurements and results: The concentration of capsaicin inducing five or more coughs (C5) was determined. Among subjects with URI, mean (± SEM) log C5 after guaifenesin and placebo were 0.92 ± 0.17 and 0.66 ± 0.14, respectively (p = 0.028). No effect on cough sensitivity was observed in healthy volunteers. Conclusions: Our results demonstrate that guaifenesin inhibits cough reflex sensitivity in subjects with URI, whose cough receptors are transiently hypersensitive, but not in healthy volunteers. Possible mechanisms include a central antitussive effect, or a peripheral effect by increased sputum volume serving as a barrier shielding cough receptors within the respiratory epithelium from the tussive stimulus.",
keywords = "Capsaicin, Common cold, Cough, Cough reflex, Expectorant, Guaifenesin, Respiratory tract infection",
author = "Dicpinigaitis, {Peter Vytautas} and Gayle, {Yvonne E.}",
year = "2003",
month = "12",
doi = "10.1378/chest.124.6.2178",
language = "English (US)",
volume = "124",
pages = "2178--2181",
journal = "Chest",
issn = "0012-3692",
publisher = "American College of Chest Physicians",
number = "6",

}

TY - JOUR

T1 - Effect of Guaifenesin on Cough Reflex Sensitivity

AU - Dicpinigaitis, Peter Vytautas

AU - Gayle, Yvonne E.

PY - 2003/12

Y1 - 2003/12

N2 - Background: Guaifenesin, a commonly used agent for the treatment of cough, is termed an expectorant since it is believed to alleviate cough discomfort by increasing sputum volume and decreasing its viscosity, thereby promoting effective cough. Despite its common usage, relatively few studies, yielding contrasting results, have been performed to investigate the action and efficacy of guaifenesin. Study objectives: To evaluate the effect of guaifenesin on cough reflex sensitivity. Design: Randomized, double-blind, placebo-controlled trial. Setting: Academic medical center. Participants: Fourteen subjects with acute viral upper respiratory tract infection (URI) and 14 healthy volunteers. Interventions: On 2 separate days, subjects underwent capsaicin cough challenge 1 to 2 h after receiving a single, 400-mg dose (capsules) of guaifenesin or matched placebo. Measurements and results: The concentration of capsaicin inducing five or more coughs (C5) was determined. Among subjects with URI, mean (± SEM) log C5 after guaifenesin and placebo were 0.92 ± 0.17 and 0.66 ± 0.14, respectively (p = 0.028). No effect on cough sensitivity was observed in healthy volunteers. Conclusions: Our results demonstrate that guaifenesin inhibits cough reflex sensitivity in subjects with URI, whose cough receptors are transiently hypersensitive, but not in healthy volunteers. Possible mechanisms include a central antitussive effect, or a peripheral effect by increased sputum volume serving as a barrier shielding cough receptors within the respiratory epithelium from the tussive stimulus.

AB - Background: Guaifenesin, a commonly used agent for the treatment of cough, is termed an expectorant since it is believed to alleviate cough discomfort by increasing sputum volume and decreasing its viscosity, thereby promoting effective cough. Despite its common usage, relatively few studies, yielding contrasting results, have been performed to investigate the action and efficacy of guaifenesin. Study objectives: To evaluate the effect of guaifenesin on cough reflex sensitivity. Design: Randomized, double-blind, placebo-controlled trial. Setting: Academic medical center. Participants: Fourteen subjects with acute viral upper respiratory tract infection (URI) and 14 healthy volunteers. Interventions: On 2 separate days, subjects underwent capsaicin cough challenge 1 to 2 h after receiving a single, 400-mg dose (capsules) of guaifenesin or matched placebo. Measurements and results: The concentration of capsaicin inducing five or more coughs (C5) was determined. Among subjects with URI, mean (± SEM) log C5 after guaifenesin and placebo were 0.92 ± 0.17 and 0.66 ± 0.14, respectively (p = 0.028). No effect on cough sensitivity was observed in healthy volunteers. Conclusions: Our results demonstrate that guaifenesin inhibits cough reflex sensitivity in subjects with URI, whose cough receptors are transiently hypersensitive, but not in healthy volunteers. Possible mechanisms include a central antitussive effect, or a peripheral effect by increased sputum volume serving as a barrier shielding cough receptors within the respiratory epithelium from the tussive stimulus.

KW - Capsaicin

KW - Common cold

KW - Cough

KW - Cough reflex

KW - Expectorant

KW - Guaifenesin

KW - Respiratory tract infection

UR - http://www.scopus.com/inward/record.url?scp=0345732494&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0345732494&partnerID=8YFLogxK

U2 - 10.1378/chest.124.6.2178

DO - 10.1378/chest.124.6.2178

M3 - Article

C2 - 14665498

AN - SCOPUS:0345732494

VL - 124

SP - 2178

EP - 2181

JO - Chest

JF - Chest

SN - 0012-3692

IS - 6

ER -